凯发一触即发

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors

Cancer Res. 2021-04; 
Lin Wang, Luz M Londono, Jessica Cowell, Ozge Saatci, Mertkaya Aras, Pelin G Ersan, Sara Serra, Hong Pei, Renee Clift, Qiping Zhao, Kim B Phan, Lei Huang, Michael J LaBarre, Xiaoming Li, H Michael Shepard, Silvia Deaglio, Joel Linden, Christopher D Thanos, Ozgur Sahin, Caglar Cekic
Products/Services Used Details Operation
Mutagenesis Services Variants were generated using the QuickChange Lightning Multi Site-Directed Mutagenesis Kit (catalog no. 210518; Agilent Technologies) and were expressed in Chinese hamster ovary-suspension cells. FLAG-tagged ADA2 variants were purified using an anti-FLAG M2 affinity resin (catalog no. L00432; GenScript). Get A Quote

摘要

Extracellular adenosine in tumors can suppress immune responses and promote tumor growth. Adenosine deaminase 2 (ADA2) converts adenosine into inosine. The role of ADA2 in cancer and whether it can target adenosine for cancer therapy has not been investigated. Here we show that increased ADA2 expression is associated with increased patient survival and enrichment of adaptive immune response pathways in several solid tumor types. Several ADA2 variants were created to improve catalytic efficiency, and PEGylation was used to prolong systemic exposure. In mice, PEGylated ADA2 (PEGADA2) inhibited tumor growth by targeting adenosine in an enzyme activity-dependent manner and thereby modulating immune responses. These... More

关键词